DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR DROSPIRENONE AND ETHINYL ESTRADIOL
All Clinical Trials for Drospirenone And Ethinyl Estradiol
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00413062 | Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2006-06-01 | The primary purpose of this study is to assess contraceptive efficacy, vaginal bleeding patterns (cycle control), general safety and acceptability of the nomegestrol acetate-estradiol (NOMAC-E2) combined oral contraceptive (COC) in a large group of women aged 18-50 years. |
| NCT00511199 | Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2006-05-01 | The primary purpose of this study is to assess contraceptive efficacy, vaginal bleeding patterns (cycle control), general safety and acceptability of the nomegestrol acetate-estradiol (NOMAC-E2) combined oral contraceptive (COC) in a large group of women aged 18-50 years. |
| NCT00511433 | Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2006-10-01 | The primary purpose of this study is to evaluate the effects of the nomegestrol acetate-estradiol (NOMAC-E2) combined oral contraceptive (COC) on ovarian function. |
| NCT00567164 | Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ | Completed | Bayer | Phase 3 | 2007-10-01 | The purpose of this study is to determine whether the study drug is safe and effective. |
| NCT00633360 | The Oral Contraceptive Pill for Premenstrual Worsening of Depression | Completed | Massachusetts General Hospital | N/A | 2008-02-01 | To determine if augmentation with the oral-contraceptive pill containing drospirenone and ethinyl estradiol is more effective than placebo in the treatment of premenstrual breakthrough of depression. |
| NCT00640224 | Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 4 | 2005-03-01 | The purpose is to investigate the effects of 2 different treatments (drospirenone/ethinyl estradiol versus rosiglitazone) on insulin sensitivity and androgen levels, inflammatory markers, vascular markers and bone development in overweight adolescent females with polycystic ovary syndrome (PCOS). |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Drospirenone And Ethinyl Estradiol
Clinical Trial Locations for Drospirenone And Ethinyl Estradiol
Trials by Country
Clinical Trial Progress for Drospirenone And Ethinyl Estradiol
Clinical Trial Phase
Clinical Trial Status
Clinical Trial Sponsors for Drospirenone And Ethinyl Estradiol
Sponsor Name
